Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
Gwen Melincoff
Equibles does not estimate personal net worth.
About Gwen Melincoff
Gwen Melincoff was last confirmed as Board Member at Gain Therapeutics, Inc. (GANX) in a filing dated April 28, 2023. Gwen Melincoff was last confirmed as Board Member at Soleno Therapeutics Inc in a filing dated April 14, 2023. Earlier roles on record: Board Member at Collegium Pharmaceutical, Inc (COLL) until March 17, 2025.
Affiliation history
-
Soleno Therapeutics Inc
Board Member
Proxy statement
2019-01-01–2023-04-14
Last confirmed by a filing; no departure on record
-
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
-
Start not stated–2025-03-17
Company network
Soleno Therapeutics Inc
Biotechnology · Healthcare
Board Member
Since 2019-01-01, last confirmed 2023-04-14
Recent activity
No call appearances or filed executive changes recorded yet.